Primex Pharmaceuticals names new global commercial head
25 October 2019 -

Primex Pharmaceuticals AG, a Switzerland-based pharmaceutical company, has named Dan Spacie as its new global commercial head, it was reported yesterday.

Dan Spacie joined Primex Pharmaceuticals from Syneos Health, where he was president, Commercial, Europe. Prior to Syneos, he held several leadership roles including managing director at STADA UK affiliates for five years. He has extensive international leadership experience in growing sales and enhancing profitability of generics, branded pharmaceuticals and launching biopharmaceuticals.

In the new role, Spacie is responsible for global Commercialisation, working with both the company's partners and direct field forces across the portfolio and with the launch of OZALIN in the European Union. He will be part of the executive team headed by CEO Alan Knox and is based in Zug, Switzerland.